Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgE < sub > Trap < /sub > -Fc protein in subjects with Atopy: Results from the First-in-Human study

CONCLUSION: This study showed that YH35324 has a favorable safety profile and is effective in reducing serum-free IgE levels in subjects with atopic conditions.PMID:38382265 | DOI:10.1016/j.intimp.2024.111706

Source: International Immunopharmacology - February 21, 2024 Category: Allergy & Immunology Authors: Young-Min Ye Jung-Won Park Sae-Hoon Kim You Sook Cho Sook Young Lee Sae Young Lee Sujin Sim Eunji Song Bomin Kim Jieon Lee Su Kyung Kim Myoung Ho Jang Hae-Sim Park Source Type: research